[1] Anstey AV, Wakelin S, Reynolds NJ.Guidelines for prescribing azathioprine in dermatology[J]. British Journal of Dermatology,2004, 151(6):1123-1132. [2] Ladrière M.Current indications of azathioprine in nephrology[J].Nephrol Ther, 2013,9(1):8-12. [3] 刘硕,秦颖,王乃栩.硫唑嘌呤的药物不良反应及合理用药概述[J]. 药物流行病学杂志, 2013,22(7):390-393. [4] 中华医学会. 临床诊疗指南.风湿病分册[M]. 北京:人民卫生出版社, 2005:1-132. [5] 张艳贤. 宫颈癌同步放化疗急性血液学毒性相关预测因子的研究[D].广西医科大学,2015. [6] 林燕芳,苏松森,周虹,等.风湿性疾病患者营养状况对使用硫唑嘌呤所致血液学毒性的影响[J]. 药物流行病学杂志, 2018,27(4):230-232. [7] 王蓉. 前白蛋白是营养状况监测的最好指标[J].国际护理学杂志, 2006(12):1043-1043. [8] 胡盼盼,王丽莉,刘志华.前白蛋白与维持性血液透析患者死亡的关系[J]. 中华肾病研究电子杂志,2018,7(5):13-16. [9] Zhou JD, Wang M, Wang HK, et al.Comparison of two nutrition assessment tools in surgical elderly inpatients in Northern China[J]. Nutrition Journal, 2015, 14(1):68. [10] Cederholm T, Bosaeus I, Barazzoni R, et al.Diagnostic criteria for malnutrition- An ESPEN Consensus Statement[J]. Clinical Nutrition, 2015, 34(3):335-340. [11] Dean L.Azathioprine Therapy and TPMT Genotype - Medical Genetics Summaries-NCBI Bookshelf[M]. National Center for Biotechnology Information, 2013. [12] Zhu Q, Cao Q.Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine[J].Chin Med J(Engl),2012,125( 20) : 3665-3670. [13] Chisick L, Oleschuk C, Bernstein CN.The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease[J]. Can J Gastroenterol, 2013, 27(1) : 39-43. [14] Naughton MA, Battaglia E, O' Brien S, et al. Identification ofthiopurine methyltransferase(TPMT)polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine[J]. Rheumatology,1999,38(7) : 640-644. [15] Cao Q, Zhu Q, Shang Y, et al.Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease[J].Digestion,2009,79(1):58-63. [16] 费祥,束庆,葛卫红.NUDTl5基因多态性与巯嘌呤类药物所致白细胞减少的研究进展[J].中国医院药学杂志,2017(37):2307-2311. [17] von Ah sen N, A rm st rong VW, Beh rens C, et al.Association of inosine t riphosphat as e 94C >A and thiopurine S-methylt ransferase deficiency with adverse event s and study dropouts under azathioprine therapy in a prospective Crohn disease study[ J].Clin Chem, 2005, 51(12):2282-2288. [18] Breen DP, Marinaki AM, Arenas M, et al.Pharmacogenetic association with adverse drug react ions to azathioprine immunosup pressive therapy following liver transplantation[J].Liver Transpl, 2005, 11(7):826-833. [19] 马晓琴,辛华雯,李维亮,等.嘌呤类药物代谢酶HGPRT和IMPDH的研究进展[J].中国药师, 2013,16(12):1907-1910. [20] 丁辉,钱家鸣,单科曙,等. 硫唑嘌呤治疗炎症性肠病的不良反应分析[J].临床消化病杂志,2011,23(1):40-47. [21] Koksal AR, Alkim C, Altinkaya E, et al.Infliximab and azathioprine- related severe neutropenia and thrombocytopenia in a case with Crohn's disease[J]. Turk J Gastroenterol, 2011,22(5) : 537-539. |